A novel cytotoxic T lymphocyte epitope analogue with enhanced activity derived from cyclooxygenase-2
Scandinavian Journal of Immunology, 06/12/2012
Wu YH et al. – The epitope analogue, especially p321–1Y9L, may be a good candidate which could be used to the immunotherapy of patients with tumors expressing cyclooxygenase–2.



